On the latest episode of "The Road to a Vaccine," host Lisa Ling delves into the effects of the pandemic on kids. We sat down with one of the guests, Vikram Patel, a professor at Harvard Medical School, to find out the most pressing questions on his mind.
Blog
On the latest episode of "The Road to a Vaccine," host Lisa Ling delves into the effects of the pandemic on kids. We sat down with one of the guests, Vikram Patel, a professor at Harvard Medical School, to find out the most pressing questions on his mind.
On August 18th, learn from CRB’s subject matter experts covering critical, relevant topics in the animal health market at this year’s Animal Health in the Heartland symposium, where the focus will be “Whole Animal Health.”
A preclinical study just published in Nature shows that the company's investigational vaccine has shown positive early data for eliciting an immune response against SARS-CoV-2, the virus that causes COVID-19. We share more about the findings from the recent preclinical study, along with other up-to-date information about the potential vaccine candidate.
Blog
A preclinical study just published in Nature shows that the company's investigational vaccine has shown positive early data for eliciting an immune response against SARS-CoV-2, the virus that causes COVID-19. We share more about the findings from the recent preclinical study, along with other up-to-date information about the potential vaccine candidate.
The clinical trial has completed full immunizations of the company's investigational HIV vaccine regimen. Learn what this means for the future of fighting the disease—and also for the creation of a potential vaccine for COVID-19.
Blog
Since the start of the pandemic, Johnson & Johnson has been working to help address the devastating impacts of COVID-19 through the power of its science, the size of its global reach—and the know-how that comes from such experiences as standing up to challenges like HIV.
Staying connected is more important than ever for all of us around the world, and in both our personal and professional lives. Enter wireless technology: It’s helping us keep in touch with friends and family, as well as work and learn remotely. It’s also supporting life-saving telemedicine and is instrumental in getting people food and other immediate resources.
In Season 2 of "The Road to a Vaccine," host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.
In Episode 2, Lisa Ling talks with Dr. Francis Collins, Director, NIH about the latest on treatments and vaccines. Also, Harvard's Dr. Ashish Jha shares how the virus affects the body and Johns Hopkins' Dr. Tom Inglesby explains what the new data on spread means for people.
In Season 2 of "The Road to a Vaccine," host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.
In the Season 2 premiere, Lisa Ling checks into the AIDS 2020 conference to talk with HIV advocate Laverne Cox and Johnson &. Johnson Chief Scientific Officer Paul Stoffels, M.D., about how HIV vaccine research is informing work on COVID-19 vaccines.
While the COVID-19 pandemic has created so much uncertainty, we remain committed to supporting people living with substance use disorders and schizophrenia and helping to assure that patients have access to our medicines.
Medtronic CEO talks with TriplePundit about delivering on our Mission during a pandemic
Article
CEO Geoff Martha was recently interviewed by TriplePundit about the company's response to COVID-19. Watch clips of the conversation, where he discusses how our Mission guided him and empowered us to put purpose over profit in a time of crisis.
